Immutep (IMMP) Free Cash Flow (2011 - 2024)
Immutep (IMMP) posted Free Cash Flow of -$22.9 million for Q2 2024, up 2.89% on a QoQ basis from -$23.6 million in Q2 2023, and up 2.89% year-over-year from -$22.3 million in Q3 2023.
Immutep (IMMP) Free Cash Flow (2011 - 2024) Analysis & Trends
Immutep's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$22.9 million for Q2 2024.
- Quarterly Free Cash Flow rose 2.89% year-over-year to -$22.9 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was -$22.9 million (up 50.73% YoY) and the FY2025 annual result came in at -$39.8 million, down 73.15% from the prior year.
- Free Cash Flow was -$22.9 million for Q2 2024 at Immutep, up from -$23.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$7.1 million in Q2 2020 and bottomed at -$23.6 million in Q2 2023.
- A 3-year average of -$17.9 million and a median of -$22.9 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2020 — Free Cash Flow soared 33.65% — and 2024, when it grew 2.89%.
- Immutep's Free Cash Flow stood at -$7.1 million in 2020, then slumped by 232.62% to -$23.6 million in 2023, then gained by 2.89% to -$22.9 million in 2024.
- Business Quant data shows IMMP's Free Cash Flow at -$22.9 million in Q2 2024, -$23.6 million in Q2 2023, and -$7.1 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -22.95 Mn |
| Jun 30, 2024 | -22.95 Mn |
| Jun 30, 2023 | -23.63 Mn |
| Jun 30, 2023 | -23.63 Mn |
| Jun 30, 2020 | -7.10 Mn |
| Jun 30, 2020 | -7.10 Mn |
| Jun 30, 2019 | -10.71 Mn |
| Jun 30, 2019 | -10.71 Mn |
| Jun 30, 2017 | -1.64 Mn |
| Jun 30, 2017 | -1.64 Mn |
| Jun 30, 2016 | -8.44 Mn |
| Jun 30, 2016 | -8.44 Mn |
| Jun 30, 2015 | -6.05 Mn |
| Jun 30, 2015 | -6.05 Mn |
| Jun 30, 2014 | -13.27 Mn |
| Jun 30, 2014 | -13.27 Mn |
| Jun 30, 2013 | -15.93 Mn |
| Jun 30, 2013 | -15.93 Mn |
| Jun 30, 2011 | -13.61 Mn |
| Jun 30, 2011 | -13.61 Mn |